Professor Ed Wild, MRCP, PhD
Editor-in-chief
London, UK

Ed Wild is a Professor of Neurology at University College London, a Consultant Neurologist at the National Hospital for Neurology and Neurosurgery in London’s Queen Square, and Associate Director of UCL Huntington’s Disease Centre. He leads a team of researchers aiming to accelerate the development of new therapies to make a real difference for people impacted by Huntington’s disease.
For more information visit edwild.com
Articles edited by Professor Ed Wild
- Huntington’s disease therapeutics conference 2022 - Day 3
- BAC to basics: a more accurate mouse model for Huntington's disease
- Vaccines and HD
- Updates from the EHDN Plenary Meeting 2020
- Huntington’s disease therapeutics conference 2020 - Day 1
- Huntington’s disease therapeutics conference 2020 - Day 3
- Unpacking Wave's PRECISION-HD2 huntingtin-lowering trial announcement
- Could molecular handcuffs lower the protein that causes Huntington's disease?
- Details emerge of first Huntington’s disease gene therapy clinical trial
- When interrupting is good: genetic hiccups that protect against Huntington's disease
- Huntington's disease therapeutics conference 2019 - Day 3
- Huntington's disease therapeutics conference 2019 - Day 2
- Huntington's disease therapeutics conference 2019 - Day 1
- Huntington's disease goes viral as UniQure inches ahead in gene therapy race
- HDSA FAQ on the Roche/Genentech RG6042 program
- Kids sometimes get Huntington’s disease too
- Roche announces details of its 'pivotal' huntingtin-lowering study
- Disappointing news from LEGATO-HD trial of laquinimod in Huntington's disease
- HDBuzz Enrolls in Enroll-HD
- New collaboration seeks to speed Huntington's disease drug licensing
- The structure of the protein that causes Huntington's disease, revealed
- Huntington's disease therapeutics conference 2018 - day 3
- Huntington's disease therapeutics conference 2018 - day 2
- Switch off the genome editor when you’re done
- A new way of thinking about trials to prevent Huntington's disease
- Has a "wonder drug" for dementia been discovered? (Spoiler alert: no.)
- Huntington's Disease Therapeutics Conference 2017 - Day 1
- Weeding out the truth: can cannabis improve Huntington’s?
- The benefits of migration, highlighted in Huntington's disease
- A powerful message: does a toxic RNA message molecule cause harm in Huntington's disease?
- Sorry folks, the PRIDE-HD trial did NOT show that Pridopidine slows the progression of Huntington's disease
- EuroBuzz 2016: The Euro-HD Network Meeting in The Hague
- Deutetrabenazine for Huntington's disease: a positive trial but the FDA says no? Not exactly...
- Slightly long CAG repeats are more common than we thought
- Electron beam snaps best images yet of Huntington's disease protein
- Huntington's Disease Therapeutics Conference 2016 - day 3
- Huntington's Disease Therapeutics Conference 2016 - day 2
- Could a new "jaw-dropping" breakthrough help treat Huntington's Disease?
- Harnessing the power of viruses to treat Huntington's disease
- A multiple sclerosis drug that works for Huntington's disease: the real deal or too good to be true?
- Huge study reveals new 'genetic modifiers' of Huntington's disease
- Would ewe believe it? GM1, sheep and Huntington's disease
- A faulty filter? Blood vessel changes in Huntington's disease
- 2015 Huntington's Disease Therapeutics Conference: Day 3
- 2015 Huntington's Disease Therapeutics Conference: Day 2
- Can this synthetic oil help feed the brain in Huntington's disease?
- Positive results announced for re-worked tetrabenazine drug in Huntington's disease
- Turning skin cells into brain cells: a Huntington's disease research breakthrough?
- Should we worry about a huntingtin invasion?
- EuroBuzz 2014 Video, day two
- Melatonin alterations in Huntington's disease help explain trouble with sleep
- EuroBuzz 2014: day two
- Going toe-to-toe with tau: new insights into the chemical basis of Huntington’s disease
- 2CARE study of coenzyme Q for Huntington's disease ends in disappointment
- A starring role for astrocytes in Huntington's disease?
- Jumping genes: Huntington's disease protein invades brain transplants
- The brain in Huntington's disease: greater than the sum of its parts?
- Raptor announces results of cysteamine trial for Huntington's disease
- Huntington's Disease Therapeutics Conference 2014: day 2
- Prana announces results of Reach2HD trial of PBT2 for Huntington's disease
- Does high-dose creatine "slow the onset" of Huntington's Disease?
- Could a 'brain shuttle' get Huntington's disease drugs to where they're needed?
- DNA shutdown proteins in Huntington's disease: More than meets the eye
- Do dairy foods accelerate Huntington's disease?
- Buzzilia Video: Day 3
- The sweet lowdown: Huntington's disease brains use sugar differently
- Buzzilia Video: Day 1
- 'Buzzilia' from the Huntington's Disease World Congress: day 4
- 'Buzzilia' from the Huntington's Disease World Congress: day 2
- How long is too long? Rethinking the Huntington’s disease ‘gray area’
- Can sad mice help treat Huntington's disease?
- Gene silencing drug safe in ALS patients... bring on Huntington's disease trials
- Splicing with danger: a new way of thinking about the harmful Huntington's disease protein
- Proposed Huntington's disease 'biomarker' is not useful, new study suggests
- Is access to predictive genetic testing for Huntington's disease a problem?
- HD Therapeutics Conference 2013 Updates: Day 3
- HD Therapeutics Conference 2013 Updates: Day 1
- Lost in translation? New insights into the making of the Huntington's disease protein
- Simple rules for a good night's sleep in Huntington's disease
- Is a new technique set to revolutionize Huntington's disease genetic testing?
- Liver changes in Huntington's disease patients suggest more 'whole body' research needed
- The 'N17' region of huntingtin protein: an address label in Huntington's disease?
- HDBuzz Special Feature: Huntington's disease and sleep
- Gone fishing: protein network screen identifies new therapeutic targets in Huntington's disease
- Prana Biotech publishes Huntington's disease animal model data for PBT2
- 'Guard dog' proteins reveal surprising connections between Huntington's disease and other brain disorders
- Dyeing to prevent dying? Methylene blue beneficial in Huntington's disease mice
- Targeting oxidative stress in Huntington's Disease
- Of mice and men: using animal models to study Huntington's disease
- HDBuzz Prize runner-up 2012: Fruit flies, faulty connections and Huntington's disease
- HDBuzz Prize winner 2012: Deep brain stimulation for HD
- Shooting the messenger with single-stranded RNA gene silencing
- EuroBuzz Video: Day 2
- EuroBuzz News: Day 3
- EuroBuzz News: Day 1
- Lithium with a twist gets second chance for HD
- High-power brain scans reveal sodium changes in HD
- Mapping the neighborhood: huntingtin's new protein partners
- 'Induced' stem cells make exciting advances
- ASO gene silencing reaches further, lasts longer
- Exercise increases cellular recycling
- What's the connection between Huntington's Disease and cancer?
- HD Therapeutics Conference 2012 Updates: Day 3
- HD Therapeutics Conference 2012 Updates: Day 1
- Special 'brain fat' injection helps HD mice
- Could mesenchymal stem cells deliver gene silencing drugs?
- New experiments clarify the role of SIRT1 in HD - or do they?
- Gene therapy meets stem cells in liver disease success
- Chinese Huntington’s Disease Network launched
- Turning down the volume with dantrolene helps HD mice
- New antibody reveals dangerous parts of huntingtin protein
- HD World Congress 2011: a retrospective
- HD just got cilia
- Gene silencing takes a targeted step forward
- Oz Buzz Video: Day 2
- Oz Buzz Updates: Day 3
- Oz Buzz Updates: Day 1
- Stem cells and HD: past, present and future
- Cut-and-paste DNA: fixing mutations with 'genome editing'
- Making babies: having a family, the HD way
- Re-routing the huntingtin protein inside cells
- Not all in your head: digestive problems in HD
- Meet the enemy: neutron ray reveals HD protein structure
- Improving Huntington's disease clinical trial recruitment through patient and family education
- Dimebon fails in late-stage human HD clinical trial
- FDA: further trial needed for Huntexil approval in HD
- Successful gene therapy trial in Parkinson’s Disease gives hope for HD
- What do sheep brains have to do with HD?
- Interview: CHDI Management
- CHDI Report: Day 3
- CHDI Report: Day 1
- Anti-nausea drug helps cells with the HD mutation stay healthy in a surprising way
- Memantine in HD: dose is everything
- An active lifestyle may make a difference to HD symptoms
- Getting the data out – a new scientific journal just for HD
- Dimebon: disappointing in Alzheimer’s but might work in HD
- Focused drug screening leads to improved drugs to increase the rate of cellular recycling
- Does HD cause brains to develop differently?
- Are there genetic connections between neurodegenerative diseases?
- Two large HD observational studies – COHORT and Registry – merge to create ENROLL-HD
- TRACK-HD reveals significant changes in pre-symptomatic HD mutation carriers and patients
Articles written by Professor Ed Wild
- Start here!
- PROOF-HD study of pridopidine ends with negative result
- KINECT-HD trial shows valbenazine improves involuntary movements in Huntington's disease
- Huntington's disease therapeutics conference 2021 - Day 3
- Huntington's disease therapeutics conference 2021 - Day 2
- What does COVID-19 mean for Huntington’s disease families and HD research?
- Huntington's disease therapeutics conference 2018 - day 1
- Ask the expert: Q&A on the huntingtin-lowering trial program
- Huntington's Disease Therapeutics Conference 2017 - Day 3
- Pfizer Amaryllis trial ends in disappointment: no improvement in Huntington's disease symptoms
- Huntington's Disease Therapeutics Conference 2016 - day 1
- 2015 Huntington's Disease Therapeutics Conference: Day 1
- Largest creatine clinical trial for Huntington's disease halted after 'futility' analysis
- EuroBuzz 2014 Video, day one
- EuroBuzz 2014: day three
- EuroBuzz 2014: day one
- Huntington's Disease Therapeutics Conference 2014: day 3
- Huntington's Disease Therapeutics Conference 2014: day 1
- Buzzilia Video: Day 2
- Video feature: Huntington's disease research... in space!
- 'Buzzilia' from the Huntington's Disease World Congress: day 3
- 'Buzzilia' from the Huntington's Disease World Congress: day 1
- Coming soon from the 2013 Huntington's Disease World Congress: Buzzilia!
- The 2013 HDBuzz Prize for Young Science Writers
- Does a 'rusty hinge' cause Huntington's disease?
- HD Therapeutics Conference 2013 Updates: Day 2
- Major Roche-Isis deal boosts Huntington's disease gene silencing
- No surprises in published results from HART study of Huntexil for Huntington's disease
- The University of New Orleans has NOT discovered a cure for Huntington's disease
- Prominent Huntington's disease researcher "fabricated data" in grant applications
- Calming down the immune system helps Huntington's disease mice
- Giving Huntington's disease the finger? Two teams report success for zinc-finger drugs in cells and mice
- Interview: Alice and Nancy Wexler
- Video: What’s new in Huntington's disease research 2012
- EuroBuzz Video: Day 1
- EuroBuzz News: Day 2
- Coming Soon: EuroBuzz 2012
- Does the HD mutation affect children's growth?
- Interview: CHDI's scientific team
- The HDBuzz Prize for young science writers
- Closing the care gap: new guidelines for HD care
- 2012 Therapeutics Conference: a retrospective
- Mutant yeast highlights crucial CAG-reading protein
- HD Therapeutics Conference 2012 Updates: Day 2
- Coming soon: HD Therapeutics Conference 2012
- New analysis suggests 'small' CAG length doesn't matter after all
- HDYO! Huntington's Disease Youth Organization goes live
- Double success for huntingtin RNAi gene silencing
- 2011 - a year in Huntington's disease research
- HDAC inhibitor drug protects memory in HD mice
- Huntexil hits the headlines again
- Safety trials add crucial piece to gene silencing jigsaw
- Melatonin treatment success in HD mice
- HDAC inhibitors and a possible 'blood biomarker'
- Prana Biotech's new trial of PBT2 in Huntington's disease: the lowdown
- Oz Buzz Video: Day 1
- Oz Buzz Updates: Day 2
- Stand By for Oz Buzz
- Ten golden rules for reading a scientific news story
- Protein-folding drug helps HD mice... for a while
- A back-to-front hidden message in the HD gene?
- Coming soon from the HD World Congress: Oz Buzz!
- Therapeutics conference videos now online
- Caffeine, cannabis and caution
- Huntexil update: EMA asks for further trial
- KMO inhibitor drug improves lifespan of Huntington's disease mice
- 'Floating' gene-silencing drugs into the brain with exosomes
- Chubby mice reveal the importance of the hypothalamus in Huntington's disease
- Gene silencing for HD: the story so far
- Interview: Graeme Bilbe, Global Head for Neuroscience at Novartis
- CHDI Report: Day 2
- HDBuzz takes your questions to the annual therapeutics meeting of CHDI
- Welcome to HDBuzz
- Frequently asked questions, January 2011
- Is Huntington’s disease twice as common as we thought?
- Huntexil for symptoms of Huntington's disease: where are we now?
- Minocycline: the end of the road?